Malignant Neoplasm of Stomach Recruiting Phase 2 Trials for Oxaliplatin (DB00526)

Also known as: Gastric Cancers / Stomach Cancer / Gastric cancer / Gastric Malignancies / Gastric cancer NOS / Cancer of Stomach / Malignant neoplasm of stomach, unspecified / Gastric malignancy

DBCOND0045917 (Malignant Neoplasm of Stomach)Recruiting2 IdentifierTitlePurposeDrugs
NCT03448835Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA)Treatment
NCT02191566S-1/Oxaliplatin for High Risk Patients Who Underwent GastrectomyTreatment
NCT03283761FOLFOX-A in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction AdenocarcinomaTreatment
NCT03263741Exploratory Study on the Paclitaxel + S-1 + Oxaliplatin (PSOX) for Locally Advanced or Advanced Gastric CancerTreatment
NCT02931890Multicentric Randomised Trial for Resectable Gastric CancerTreatment
NCT02954536Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) CancerTreatment
NCT03421288Phase II Study of Atezolizumab + FLOT vs. FLOT Alone in Patients With Gastric Cancer and GEJTreatment
NCT03505320A Study to Assess the Antitumor Activity, Safety, Pharmacokinetics and Biomarkers of Zolbetuximab (IMAB362) in Participants With Claudin (CLDN) 18.2 Positive, Metastatic or Advanced Unresectable Gastric and Gastroesophageal Junction (GEJ) AdenocarcinomaTreatment
NCT03817411Telatinib in Combination With Capecitabine/ Oxaliplatin in 1st Line Gastric or GEJ CancerTreatment
NCT03342937KeyLargo: Pembrolizumab + Oxaliplatin + Capecitabine in Gastric CancerTreatment
NCT03472365A Study of SHR-1210 in Combination With Capecitabine + Oxaliplatin or Apatinib in Treatment of Advanced Gastric CancerTreatment
NCT03007446The Study of Conversion Surgery for Apatinib in Combination With SOX for Patients With Unresectable Gastric CancerTreatment
NCT02725424Optimizing the Strategy for Preoperative Chemotherapy in Locally Advanced Gastric/Gastroesophageal CancerTreatment
NCT01665274Efficiency of XELOX Neoadjuvant Chemotherapy in Gastric CancerTreatment
NCT01679340A Phaseâ…¡ Study: SOX vs SP in Adjuvant Chemotherapy After D2 SurgeryPrevention
NCT02250209T- XELOX in HER2-positive Stage III Gastric Cancer After D2 GastrectomyTreatment
NCT02504229DC-CIK In Combination With Chemotherapy ( Gio / Oxaliplatin or Cisplatin ) Versus First-line Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma Randomized Controlled Phase II Clinical Study of TreatmentTreatment